Announcements Trials
Browse Landscape

Status

No longer available 1Completed 1

Sponsor Class

OTHER 1

Study Type

Expanded_access 1

Sponsor

Conditions

Prostatic Neoplasms 9Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Neuroblastoma 5Multiple Myeloma 5Lambert-Eaton Myasthenic Syndrome 5Leukemia 4Carcinoma, Hepatocellular 4Precancerous Conditions 3Pheochromocytoma 3Neuroendocrine Tumors 3Myelodysplastic Syndromes 3Lymphoma 3Leukemia, Myeloid, Acute 3Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3Glioblastoma 3Carcinoid Tumor 3Sarcoma, Ewing 2Sarcoma 2Paraganglioma 2Neoplasms 2Neoplasm Metastasis 2Melanoma 2Liver Neoplasms 2Immunoproliferative Disorders 2Immune System Diseases 2Hodgkin Disease 2Graft vs Host Disease 2Glioma 2Wilms Tumor 1Waldenstrom Macroglobulinemia 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
No longer available × OTHER × Advanced Malignancy × Clear all
NCT01945164 2014-10-21

XL999 Administered Intravenously to a Subject With Advanced Malignancies

The University of Texas Health Science Center at San Antonio

No longer available

Advanced Malignancy

Data powered by HemOnc (CC BY 4.0) Colophon âš¡